BIOCRYST SCHEDULED TO PRESENT AT WALL STREET ANALYST FORUM

February 7, 2002
BIOCRYST SCHEDULED TO PRESENT AT WALL STREET ANALYST FORUM Birmingham, Alabama - February 7, 2002 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) Chairman and CEO, Charles E. Bugg, Ph.D., is scheduled to present at the Wall Street Analyst Forum on Tuesday, February 12, 2002, at 2:40 p.m. EST. The conference is being held at The Roosevelt Hotel in New York City. Interested investors can listen to the call live over the Internet during the conference at the following address: http://media.corporate-ir.net/media_files/priv/wsaf/event/021102.htm.

What:BioCryst Pharmaceuticals, Inc. Presentation at the Wall Street Analyst Forum
When:Tuesday, February 12, 2002, 2:40 p.m., EST
Where:http://media.corporate-ir.net/media_files/priv/wsaf/event/021102.htm.
How: Live over the Internet -- Simply log on to the web at the address above

Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of pharmaceuticals for the treatment of antiviral, inflammatory/autoimmune and cardiovascular diseases and disorders.

For those unable to listen at the designated time, the webcast will remain available for replay on http://media.corporate-ir.net/media_files/priv/wsaf/event/021102.htm for 30 days following the conference.